MEDIGUS LTD's ticker is MDGS and the CUSIP is 58471G300.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $26,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q3 2019 | $26,000 | -29.7% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $37,000 | -15.9% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $44,000 | +12.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $39,000 | -23.5% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $51,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 13,000 | $25,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21,838 | $42,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $2,000 | 0.00% |
| Geneos Wealth Management Inc. | 1,200 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 5,000 | $10,000 | 0.00% |